Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Pompe - Disease

Drug

Open in the dashboard

General payments

$21,087

1,156 payments

Research payments

$90,797

79 payments

Through program year 2019, $21,087 in general payments and $90,797 in research payments were reported against Pompe - Disease.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $21,087 1,156
2019 Research $90,797 79

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $20,997 1,151 payments
  2. Sanofi-Aventis U.S. LLC $89 5 payments
Top recipients General payments · program year 2019
  1. Timothy Quan Rheumatology · South Windsor, CT $104 <1% · 6 payments
  2. Bruce Silverman Neurology · Farmington Hills, MI $104 <1% · 5 payments
  3. Amy Goldstein Endocrinology, Diabetes & Metabolism · Philadelphia, PA $99 <1% · 1 payment
  4. Joseph Acosta Neurology · Baton Rouge, LA $90 <1% · 4 payments
  5. Kevin Callerame Neurology · Baton Rouge, LA $89 <1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $11,654 56% · 491 practitioners
  2. Pulmonary Disease Internal Medicine $1,733 8% · 91 practitioners
  3. Rheumatology Internal Medicine $1,087 5% · 47 practitioners
  4. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $1,004 5% · 41 practitioners
  5. Pediatrics $667 3% · 36 practitioners

The top 5 of 57 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Texas $1,898 9% · 72 recipients
  2. Michigan $1,565 7% · 57 recipients
  3. Georgia $1,480 7% · 62 recipients
  4. Ohio $1,350 6% · 57 recipients
  5. Virginia $1,297 6% · 62 recipients

The top 5 of 46 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

1,156 general · 79 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record